Wellnex Life (ASX:WNX) said it settled in full the deferred consideration for the Pain Away acquisition, resulting in annualized cost savings of around AU$600,000, according to a Friday filing with the Australian bourse.
It added that no further obligations to the Pain Away vendors remain.
A further disclosure will be issued at the beginning of trading on the AIM market of the London Stock Exchange on Friday.
Its shares fell over 5% on market close.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.